Cancer Accelerates Biological Aging by 3-7 Months in Healthy Older Adults
New research reveals cancer speeds up biological aging and physical decline in healthy seniors over just three years.
Summary
A groundbreaking three-year study of over 2,000 healthy older adults found that those who developed cancer experienced accelerated biological aging of 3.5 to 6.8 months compared to their actual age. Researchers tracked participants using advanced aging clocks and physical function tests. Cancer patients showed greater declines in grip strength and the ability to stand from a chair five times. The study used multiple biological aging measures including Horvath, Hannum, and PhenoAge clocks to assess cellular aging. This research supports the geroscience hypothesis that cancer and aging share common biological pathways, suggesting that targeting aging processes might help prevent or treat cancer.
Detailed Summary
This landmark study provides compelling evidence that cancer accelerates the aging process in older adults, offering new insights into the relationship between cancer and biological aging. Understanding this connection could revolutionize how we approach cancer prevention and treatment in aging populations.
Researchers followed 2,152 generally healthy adults (average age 75) for three years as part of the DO-HEALTH trial. They measured both physical function through tests like grip strength and chair stands, and biological aging using advanced epigenetic clocks that analyze DNA methylation patterns to determine cellular age versus chronological age.
Participants who developed cancer showed significantly accelerated biological aging, with their cells aging an extra 3.5 to 6.8 months beyond their chronological age. They also experienced greater functional decline, losing more grip strength and taking longer to complete chair stand tests compared to cancer-free participants. Multiple aging clocks confirmed these findings, strengthening the evidence.
These findings support the geroscience hypothesis that aging and cancer share common biological pathways. This suggests that interventions targeting aging processes might simultaneously reduce cancer risk and improve outcomes. The research also indicates that biological age, not just chronological age, may be crucial for cancer prognosis and treatment decisions.
However, the study focused on generally healthy older adults, so results may not apply to younger populations or those with existing health conditions. The biological aging measurements, while sophisticated, represent associations rather than definitive causal relationships between cancer and accelerated aging.
Key Findings
- Cancer patients showed 3.5-6.8 months of accelerated biological aging beyond chronological age
- Grip strength declined significantly more in cancer patients versus healthy controls
- Chair stand test performance worsened more dramatically in those who developed cancer
- Multiple epigenetic aging clocks confirmed accelerated cellular aging in cancer patients
- Physical function decline correlated with biological aging acceleration
Methodology
Three-year randomized controlled trial following 2,152 healthy adults (mean age 74.9). Biological aging measured in 777 participants using Horvath, Hannum, GrimAge, PhenoAge clocks, and DunedinPACE. Physical function assessed through standardized performance tests.
Study Limitations
Study limited to generally healthy older adults, potentially limiting generalizability to younger or sicker populations. Biological aging measurements show associations rather than proving causation. Long-term outcomes beyond three years remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.